Purchase Order 75F40125P00223
- Not listed
- The Food and Drug Administration awarded a $4.5M firm fixed-price definitive contract to Ivyhill-Zai, LLC for CDER/OBI Document Room Operations, with completion targeted for June 8, 2026. This 8(a) sole source award supports document management and operational services for the Center for Drug Evaluation and Research's Office of Bioavailability and Biopharmaceutics. The contract will be performed at the FDA's facility in Hyattsville, Maryland. Ivyhill-Zai is an SBA-certified 8(a) joint venture...
- This is a one-year, firm-fixed-price records management operational support contract for the U.S. Food and Drug Administration (FDA), Office of Enterprise Management Services (OEMS), awarded as a Direct 8(a) Sole Source to Ivyhill-Zai, LLC, a Minority Owned, Small Disadvantaged, and Women-Owned Small Business. The contract has a ceiling value of $4,023,568.56 and includes three one-year option periods, with a potential period of performance through July 31, 2029. As an 8(a) Sole Source award,...
- The Food and Drug Administration (FDA) awarded a 12-month, firm fixed-price contract valued at $859,066.90 to Ivyhill-Zai, LLC on September 4, 2025, under the 8(a) Sole Source set-aside program. The contract, structured as a purchase order, supports the FDA's Human Foods Program through record management services for the Human Foods Product Complaint System (HFCS). Ivyhill-Zai, LLC, a minority-owned and small disadvantaged business joint venture with SBA 8(a) certification, will perform the work...
- <p>This is a definitive, firm fixed-price contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Ivyhill-Zai, LLC, a minority-owned, 8(a) joint venture small business, for HFP/DITM/RDB/O & M RECORDS MANAGEMENT services. The contract has a total ceiling value of $461,519.63 and a period of performance ending on September 21, 2026. This contract does not have a set-aside designation. The place of performance is Cheverly, Maryland.</p>
- This is a 12-month, firm fixed-price (FFP) contract awarded by the Food and Drug Administration (FDA) to Ivyhill-Zai, LLC, an 8(a) certified small disadvantaged business, for data management support services for the FDA's Industry Systems (FIS) and Food Facility Registration (FFR) programs. The contract has a ceiling value of $938,794.91 and the period of performance runs from July 29, 2025 to July 29, 2026. As an 8(a) sole source award, this contract is set aside for small disadvantaged...
- The U.S. Food and Drug Administration (FDA) awarded a direct 8(a) sole source, firm fixed price contract to Ivyhill-Zai, LLC for the Petition Optical Workflow Exchange and Retrieval (POWER) system for the FDA's Human Foods Program. The 12-month base period contract has four additional 12-month option periods, with a total potential value of $4,343,091.68. Ivyhill-Zai, LLC is a minority-owned, small disadvantaged business and joint venture woman-owned small business located in Hyattsville,...
- The federal contract award is for "RECORDS MANAGEMENT SUPPORT" services provided by Mpf-Zai Solutions LLC, a minority-owned and woman-owned small business. The $147,978 firm-fixed price delivery order was issued by the Food and Drug Administration (FDA) on August 29, 2022, with a period of performance through August 31, 2023. This award is under a larger $112 million single-award Indefinite Delivery Vehicle (IDV) that Mpf-Zai Solutions holds with the FDA to provide comprehensive...
- This federal contract award was issued by the Food and Drug Administration (FDA) to Mpf-Zai Solutions LLC, a minority and woman-owned small business. The $1,783,011 firm fixed-price delivery order supports the FDA's records management program, which aims to promote the management of records throughout their lifecycle. Mpf-Zai Solutions is responsible for performing all elements of the statement of work (SOW), which likely includes tasks such as preparing and maintaining a detailed project...
- The Food and Drug Administration (FDA) awarded a $4,812,979.00 Firm Fixed Price delivery order to Mpf-Zai Solutions LLC, a minority and woman-owned small business, to provide document control center support services for the FDA's Center for Drug Evaluation and Research (CDER). This award is part of a larger $112 million single-award Indefinite Delivery Vehicle (IDV) contract with the FDA, which was set aside for competitive 8(a) firms. Mpf-Zai Solutions has also received multiple task orders...
- This federal contract award is for a task order under the Food and Drug Administration's (FDA) $112 million single-award Indefinite Delivery Vehicle (IDV) for comprehensive records information management services across the agency. The task order, titled "CDER P3 Operations Management," is for $1,082,981 and has a completion date of September 17, 2025. The contract was awarded to Mpf-Zai Solutions LLC, a minority and woman-owned small business that specializes in supporting...
The Food and Drug Administration (FDA) awarded a one-year, firm fixed-price purchase order valued at $459,077 to Ivyhill-Zai, LLC on September 16, 2025, under the 8(a) sole source set-aside program. The contract supports the Center for Drug Evaluation and Research (CDER) Records Management Initiative by providing professional records management support services. Work will be performed in Silver Spring, Maryland, with an ultimate completion date of September 27, 2026. Ivyhill-Zai, LLC is a minority-owned, small disadvantaged business and women-owned small business joint venture certified by the Small Business Administration under the 8(a) program through June 2, 2027. Ivyhill-Zai, LLC has established itself as a specialized service provider to the FDA, having secured approximately $16.7 million in federal contracts over the past year, predominantly through 8(a) sole source awards. The company's contract portfolio reflects expertise in document management, records management operations, and digital workflow systems across multiple FDA centers and offices. This CDER records management contract aligns with the company's core competencies and represents part of its ongoing support for the agency's administrative and operational functions related to pharmaceutical review and regulatory documentation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $459.1k | 9/16/25 |